Italian cholesterol study tracks Real-World use of new injection drug
NCT ID NCT06287177
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 3,000 adults in Italy who are already taking Inclisiran, a long-acting injection for high cholesterol. Researchers want to see how consistently patients take the medication and how much it lowers their LDL ("bad") cholesterol in everyday practice. The goal is to understand real-world effectiveness and adherence patterns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federico II University of Naples, Department of Advanced Biomedical Sciences
RECRUITINGNaples, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••